Sundial SNDL stock analysis & why SNDL stock is lagging

EC grants approval for Menarini’s breast cancer therapy

The EC’s decision comes after the EMA’s Committee for Medicinal Products for Human Use provided a positive opinion recommending approval for Orserdu. Credit: ORION PRODUCTION/Shutterstock.com.

September 21, 2023

Up and down the ladder: The latest comings and goings

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s

September 15, 2023

Motor Function in Spinal Muscular Atrophy May Improve With Adjunctive Apitegromab

Some patients with later-onset spinal muscular atrophy (SMA) type 2 and type 3 had improved motor function when the investigational monoclonal antibody apitegromab was added

February 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.